Zubair Khalid

Virologist/Molecular Biologist | Veterinarian | Bioinformatician

Conventional & Molecular Virology • Vaccine Development • Computational Biology

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Dr. Zubair Khalid - Veterinarian, Virologist, and Vaccine Development Researcher specializing in Computational Biology, Multi-omics, Animal Health, and Infectious Disease Research

Section: Pet Parasites

Angiostrongylus vasorum (French Heartworm): A Comprehensive Veterinary Reference

Scientific illustration of the angiostrongylus vasorum (french heartworm) parasite life stage
Illustration generated with AI for editorial purposes.

Introduction and Etiology

Angiostrongylus vasorum, commonly referred to as French heartworm, is a metastrongyloid nematode parasite that resides in the pulmonary arteries and right ventricle of canids and other carnivores [1, 2]. The parasite was first described by Baillet in 1866 and later assigned to the genus Angiostrongylus by Kamensky in 1905 [3]. Unlike the filarial nematode Dirofilaria immitis (canine heartworm), which occupies a similar anatomical niche, A. vasorum belongs to the superfamily Metastrongyloidea and is classified within the family Angiostrongylidae [4, 5]. The adult worms are slender, reddish-brown, and measure approximately 14-20 mm in length for males and 18-34 mm for females [2, 6]. The parasite exhibits a complex indirect life cycle requiring gastropod intermediate hosts and a range of paratenic hosts [7, 8].

Life Cycle and Transmission

The life cycle of A. vasorum is indirect and involves terrestrial and aquatic gastropods as obligate intermediate hosts [9, 4]. Adult female worms residing in the pulmonary arteries of definitive hosts produce embryonated eggs that hatch into first-stage larvae (L1) within the pulmonary capillaries [2, 10]. These L1 larvae penetrate the alveolar walls, migrate up the tracheobronchial tree, are coughed up, swallowed, and subsequently passed in the feces of the infected definitive host [1, 11].

Gastropod intermediate hosts, including slugs and snails from genera such as Arion, Helix, and Lissachatina, become infected by ingesting L1 larvae from contaminated environments [7, 9, 8]. Within the gastropod, the larvae undergo two molts to develop into infective third-stage larvae (L3) over a period of approximately 3-4 weeks, depending on ambient temperature [7, 8]. The L3 larvae exhibit organ tropism within the gastropod, preferentially accumulating in the foot and mantle tissues [8]. Definitive hosts become infected through the ingestion of gastropods containing L3 larvae [3]. Paratenic hosts, including frogs, rodents, and birds, can also harbor L3 larvae and contribute to transmission when consumed by definitive hosts [3, 5]. The prepatent period in dogs ranges from 38 to 60 days post-infection [12, 11].

graph TD
    A[Adult worms in pulmonary arteries and right ventricle], > B[Embryonated eggs in pulmonary capillaries]
    B, > C[L1 larvae hatch, penetrate alveoli]
    C, > D[L1 migrate up trachea, swallowed, passed in feces]
    D, > E[Gastropod intermediate host ingests L1]
    E, > F[L1 develop to L3 within gastropod]
    F, > G[Definitive host ingests gastropod or paratenic host with L3]
    G, > H[L3 penetrate intestinal wall, migrate to liver and lymph nodes]
    H, > I[L4 and L5 develop, migrate to pulmonary arteries]
    I, > A

Epidemiology and Geographic Distribution

Angiostrongylus vasorum was historically considered endemic to Europe, but recent molecular and epidemiological surveys have documented a rapidly expanding geographic range [1, 13, 14, 15]. The parasite is now recognized in North America, South America, Africa, and the Middle East [16, 17, 18, 15, 19]. In Europe, hyperendemic foci have been identified in southern Germany, Portugal, Italy, and parts of Scandinavia [9, 13, 14, 11]. The first autochthonous cases have been confirmed in Estonia, Norway, mainland Canada, and the United States, indicating ongoing range expansion likely facilitated by climate change and increased movement of reservoir hosts [1, 6, 11, 19].

Wild canids, particularly red foxes (Vulpes vulpes) and golden jackals (Canis aureus), serve as important reservoir hosts and contribute to environmental contamination [20, 21, 22, 23]. Other wild carnivores, including wolves (Canis lupus), Eurasian lynxes (Lynx lynx), coyotes (Canis latrans), and black bears (Ursus americanus), have been identified as definitive hosts in various regions [21, 4, 24, 17, 18]. The African golden wolf (Canis lupaster) has also been reported as a novel host in Algeria [16]. Invasive carnivore species in regions such as Hungary and the Canary Islands may facilitate further spread [20, 5]. Prevalence rates in domestic dog populations vary widely, ranging from less than 1% in low-endemic areas to over 20% in hyperendemic foci [13, 14].

Pathogenesis and Pathophysiology

The pathogenesis of canine angiostrongylosis is multifactorial and involves mechanical, inflammatory, and hemostatic derangements [10, 25, 26]. Adult worms residing in the pulmonary arteries cause endothelial damage, intimal proliferation, and thrombosis, leading to pulmonary hypertension and right-sided heart failure [27, 28]. The presence of eggs and L1 larvae in pulmonary capillaries triggers a granulomatous inflammatory response, resulting in interstitial pneumonia and alveolar consolidation [2, 6].

Transcriptomic analyses of infected dogs have revealed increased metallopeptidase activity, compromised endothelial integrity, and impaired pathogen recognition [10]. These changes are associated with a hypocoagulable state and vascular dysfunction [10]. Proteomic studies have demonstrated that adult worm homogenates induce endothelial activation, promoting vascular remodeling and hemostatic imbalance [25]. N-terminomics profiling has identified host proteins targeted by excretory-secretory proteases of A. vasorum, revealing specific points of interaction with the canine coagulation and complement cascades [26]. These interactions result in decreased von Willebrand factor levels, prolonged coagulation times, and a bleeding diathesis [26, 28].

Hypercalcemia has been reported as a primary finding in some cases, likely mediated by granulomatous inflammation and increased calcitriol production [6]. Central nervous system involvement, including cerebrovascular accidents and granulomatous encephalitis, can occur due to aberrant larval migration or thromboembolic events [2, 28].

Clinical Signs

The clinical presentation of angiostrongylosis is highly variable and ranges from subclinical infection to sudden death [2, 27]. Respiratory signs are most common and include coughing, dyspnea, tachypnea, and exercise intolerance [27, 11]. Hemostatic abnormalities manifest as epistaxis, hemoptysis, ecchymoses, petechiae, prolonged bleeding from venipuncture sites, and hyphema [10, 6, 29, 28]. Neurological signs, including seizures, ataxia, paresis, and hemiparesis, may result from cerebrovascular thromboembolism or aberrant larval migration [2, 28]. Gastrointestinal signs such as vomiting and diarrhea are less common but have been reported [6, 11]. Sudden death can occur due to massive pulmonary thromboembolism or cerebral hemorrhage [2].

Diagnostic Approaches

Coprological Examination

Detection of L1 larvae in feces is the most commonly employed diagnostic method [1, 11]. The Baermann funnel technique is considered the gold standard for larval recovery, as it concentrates larvae from fecal samples through active migration [1, 13]. First-stage larvae of A. vasorum are approximately 310-400 µm in length, possess a characteristic kinked tail with a dorsal spine, and must be differentiated from other metastrongyloid larvae such as Crenosoma vulpis and Aelurostrongylus abstrusus [1, 4]. False-negative results can occur due to intermittent larval shedding, low parasite burdens, or improper sample handling [1, 11].

Molecular Diagnostics

Conventional and real-time polymerase chain reaction (PCR) assays targeting the internal transcribed spacer 2 (ITS-2) region of ribosomal DNA or the cytochrome c oxidase subunit I (COI) gene of mitochondrial DNA provide high sensitivity and specificity for species identification [1, 15]. These assays can be performed on fecal samples, bronchoalveolar lavage fluid, or tissue specimens [2, 15]. Molecular methods are particularly valuable for confirming infections in cases with low larval output or when morphological identification is ambiguous [1, 15]. Cryptic genetic diversity has been identified among A. vasorum isolates from the Americas, suggesting the existence of distinct lineages [15].

Serological Assays

Commercial enzyme-linked immunosorbent assays (ELISAs) detecting circulating antigen of adult A. vasorum are available and offer high sensitivity for detecting patent infections [12, 30]. Antigen detection is particularly useful for screening purposes and for monitoring treatment efficacy [12]. Antibody-based assays are also available but cannot distinguish between current and past infections [30].

Hematological and Biochemical Abnormalities

Hematological findings may include eosinophilia, thrombocytopenia, and anemia [10, 6]. Coagulation abnormalities include prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), as well as decreased von Willebrand factor levels [10, 26, 28]. Serum biochemistry may reveal hypercalcemia, hyperglobulinemia, and elevated liver enzyme activities [6, 29]. Serum protein electrophoresis may demonstrate an unusual electrophoretic pattern characterized by a monoclonal or oligoclonal gammopathy, which can be mistaken for plasma cell neoplasia [31, 29].

Diagnostic Imaging

Thoracic radiography typically reveals a diffuse interstitial to bronchial pattern, often with a caudodorsal distribution [27, 28]. Pulmonary artery enlargement and right-sided cardiomegaly may be evident in chronic cases [27]. Computed tomography (CT) provides superior detail and can demonstrate pulmonary parenchymal lesions, arterial thrombosis, and bronchiectasis [28]. Brain magnetic resonance imaging (MRI) may reveal multifocal hemorrhagic or ischemic lesions in dogs with neurological signs [28]. Echocardiography can identify pulmonary hypertension and assess right ventricular function [27].

Treatment and Management

The treatment of canine angiostrongylosis involves the administration of macrocyclic lactones, often in combination with other anthelmintics [12]. A chewable tablet containing sarolaner, moxidectin, and pyrantel has demonstrated safety and efficacy for the treatment of A. vasorum infection in dogs [12]. Moxidectin, a macrocyclic lactone, is the primary active ingredient responsible for adulticidal and larvicidal activity [12]. Alternative treatment protocols include the use of fenbendazole at 50 mg/kg daily for 7-21 days, or milbemycin oxime at 0.5 mg/kg weekly for 4 weeks [12].

Supportive care is essential for dogs with severe respiratory distress, coagulopathy, or pulmonary hypertension [27]. Corticosteroids may be indicated to reduce granulomatous inflammation, but their use must be carefully weighed against the risk of immunosuppression [30]. Exercise restriction is recommended during treatment to reduce the risk of pulmonary thromboembolism [27]. Follow-up fecal examinations using the Baermann technique should be performed 4-6 weeks after treatment to confirm parasite clearance [12].

Prevention and Control

Prevention of angiostrongylosis relies on reducing exposure to gastropod intermediate hosts and the use of prophylactic anthelmintics [12, 9]. Monthly administration of macrocyclic lactones, including moxidectin and milbemycin oxime, has been shown to prevent the establishment of infection [12]. Environmental management, including the removal of debris and vegetation that harbor gastropods, can reduce the risk of exposure [9]. In endemic areas, routine screening of at-risk dogs using fecal examination or antigen testing is recommended [13, 14].

Public Health Considerations

Angiostrongylus vasorum is not considered a zoonotic pathogen, as the parasite does not complete its life cycle in humans [20, 5]. However, the closely related species Angiostrongylus cantonensis (rat lungworm) is a known cause of eosinophilic meningitis in humans [5]. The distinction between these species is important for accurate risk communication [5].

Frequently Asked Questions

What is the primary definitive host for Angiostrongylus vasorum?

The domestic dog (Canis lupus familiaris) is the primary definitive host, but red foxes, golden jackals, wolves, coyotes, and other wild canids serve as important reservoir hosts [20, 21, 22, 23, 18].

How is Angiostrongylus vasorum transmitted to dogs?

Dogs become infected by ingesting gastropod intermediate hosts (slugs and snails) containing infective third-stage larvae, or by consuming paratenic hosts such as frogs, rodents, or birds that harbor these larvae [7, 3, 8, 5].

What are the most common clinical signs of angiostrongylosis?

Respiratory signs (coughing, dyspnea), hemostatic abnormalities (epistaxis, ecchymoses, prolonged bleeding), and neurological signs (seizures, ataxia, paresis) are the most common clinical presentations [2, 10, 27, 28].

How is angiostrongylosis diagnosed?

Diagnosis is achieved through detection of first-stage larvae in feces using the Baermann funnel technique, molecular assays (PCR), antigen detection via ELISA, or a combination of these methods [1, 12, 30, 13, 11, 15].

What is the treatment of choice for Angiostrongylus vasorum infection?

A chewable tablet containing sarolaner, moxidectin, and pyrantel is an approved and effective treatment [12]. Alternative protocols include fenbendazole or milbemycin oxime [12].

Can Angiostrongylus vasorum infect humans?

No, A. vasorum is not considered zoonotic. The related species A. cantonensis is the primary cause of human angiostrongylosis [20, 5].

Is angiostrongylosis preventable?

Yes, monthly administration of macrocyclic lactones (moxidectin or milbemycin oxime) and reducing exposure to gastropod intermediate hosts are effective preventive measures [12, 9].

References

[1] Mõtsküla M, Mõtsküla PF, Saarma U. First molecularly confirmed Angiostrongylus vasorum infection in a dog in Estonia: Translocation risks and diagnostic pitfalls. J Helminthol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42317033/

[2] Dembowski M, Pütsch K, Delling C, et al. Disseminated angiostrongylosis with involvement of the central nervous system as a cause of sudden death in a dog in Germany. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42174611/

[3] Resende Ávila I, Gomes de Oliveira W, de Jesus Pereira CA, et al. Biomphalaria glabrata (Say, 1818) as a paratenic host of Angiostrongylus vasorum (Baillet,1866) Kamensky, 1905. Exp Parasitol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40049270/

[4] Haas M, Segeritz L, Anders O, et al. Patent Troglostrongylus brevior-, Aelurostrongylus abstrusus-, Angiostrongylus sp.-, and Crenosoma sp. infections in wild Eurasian lynxes (Lynx lynx) and their habitat-sharing gastropod intermediate hosts. Front Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40678497/

[5] Izquierdo-Rodriguez E, Hrazdilová K, Anettová L, et al. Co-introduction into a delicate island ecosystem: metastrongyloid nematodes (superfamily Metastrongyloidea) of veterinary and medical importance circulating in aquatic and terrestrial environments of Tenerife (Canary Islands). Parasitol Res. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39382760/

[6] Knap CM, Ross S, Bourassi E, et al. Hypercalcemia as the primary finding in the first autochthonous Angiostrongylus vasorum (French heartworm) case in a dog from mainland Canada. Can Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42095168/

[7] van de Sanden JT, Dusch A, Westhoff KM, et al. Radiolabeling of Angiostrongylus vasorum- and Crenosoma striatum larvae: a novel method using PET/CT to unveil larval migration in the gastropod intermediate host (Lissachatina fulica). Parasit Vectors. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41254713/

[8] Dusch A, Segeritz L, Henrich M, et al. Organ Tropism of Angiostrongylus vasorum Larval Stages in Infected African Giant Snails (Lissachatina fulica). Pathogens. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39599499/

[9] Dusch A, Segeritz L, Schmiedel J, et al. Re-Evaluation of a Hyperendemic Focus of Metastrongyloid Lungworm Infections in Gastropod Intermediate Hosts in Southern Germany. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40872310/

[10] Tritten L, Tayyrov A, Opitz L, et al. Increased metallopeptidase activity, compromised endothelial integrity and impaired pathogen recognition revealed by transcriptomics in Angiostrongylus vasorum-infected dogs with hypocoagulability and vascular dysfunction. Curr Res Parasitol Vector Borne Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42164837/

[11] Robbestad J, Jiménez-Meléndez A, Robertson LJ, et al. First case of autochthonous Angiostrongylus vasorum infection in a Norwegian dog. Acta Vet Scand. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39223595/

[12] Lloyd A, Van Mechelen L, Van Overloop C, et al. Safety and efficacy assessment of a chewable tablet containing sarolaner, moxidectin, and pyrantel in the treatment of Angiostrongylus vasorum in dogs. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41259838/

[13] Leal-Sousa B, Esteves-Guimarães J, Matos JI, et al. Epidemiological Mapping of Canine Angiostrongylosis in Portugal: Findings from a Nationwide Prevalence Survey. Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40711307/

[14] Traversa D, Morelli S, Di Cesare A, et al. Current Enzooticity of Dirofilaria immitis and Angiostrongylus vasorum in Central and Southern Italy. Animals (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39858171/

[15] Robleto-Quesada J, Umaña-Blanco F, Solano-Barquero A, et al. Seek, and you will find: Cryptic diversity of the cardiopulmonary nematode Angiostrongylus vasorum in the Americas. Acta Trop. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39098751/

[16] Mechouck N, Deak G, Ionică AM, et al. First report of Angiostrongylus vasorum in an African golden wolf (Canis lupaster) in Algeria. Parasit Vectors. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39468624/

[17] Riese K, Baker E, Dennis MM, et al. Corrigendum to "Two cases of Angiostrongylus vasorum, a cardiopulmonary nematode, in a wild black bear and coyote of Tennessee". Vet Parasitol Reg Stud Reports. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39326958/

[18] Riese K, Baker E, Dennis MM, et al. Two cases of Angiostrongylus vasorum, a cardiopulmonary nematode, in a wild black bear and coyote of Tennessee. Vet Parasitol Reg Stud Reports. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39237243/

[19] Williams LBA, Buswell ML, Perisho NA. First autochthonous case of Angiostrongylus vasorum in a domestic dog in the United States. J Am Vet Med Assoc. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39094624/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[20] Szentiványi T, Bruszniczky B, Biró Z, et al. Unwelcome guests: Nematodes of zoonotic and animal health importance in native and invasive carnivores of Hungary. Curr Res Parasitol Vector Borne Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42057917/

[21] Defourny SVP, Colombo M, D'Amico G, et al. Parasitic surveillance in wolves of central Italy: a focus on the Abruzzo region. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41723515/

[22] Mitrea IB, Iani AD, Gherman CM, et al. Golden jackals (Canis aureus) as novel hosts for Angiostrongylus vasorum in Romania. Vet Parasitol Reg Stud Reports. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40967693/

[23] Stevanović O, Despotović D, Ilić T, et al. Angiostrongylus vasorum in golden jackals (Canis aureus) and red foxes (Vulpes vulpes) from Northern Bosnia and Herzegovina. Parasitol Res. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39414642/

[24] Cafiero SA, Petroni L, Natucci L, et al. Parasite diversity in grey wolves (Canis lupus) from Tuscany, central Italy: a copromicroscopical investigation. Int J Parasitol Parasites Wildl. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40606262/

[25] Collado-Cuadrado M, Rodríguez-Escolar I, Balmori-de la Puente A, et al. Proteomic Analysis of Endothelial Activation Induced by Adult Angiostrongylus vasorum Homogenate: Insights into Vascular Remodeling and Hemostatic Imbalance. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41897903/

[26] Germitsch N, Kockmann T, Schnyder M, et al. N-terminomics profiling of host proteins targeted by excretory-secretory proteases of the nematode Angiostrongylus vasorum identifies points of interaction with canine coagulation and complement cascade. PLoS One. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39813225/

[27] Turner R, Connolly D, Brodbelt D, et al. The long-term outcome and changes in tricuspid regurgitation pressure gradient in dogs diagnosed with pulmonary hypertension and Angiostrongylus vasorum infestation. J Small Anim Pract. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40579840/

[28] Krüger BT, Hamm Vinga C, Wennemuth J. Brain MRI findings and thoracic CT findings in a dog with hemiparesis and acutely diminished Von-Willebrand factor levels through Angiostrongylus vasorum infection. Vet Radiol Ultrasound. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39681981/

[29] Kéfer A, Machiels H, Vincken G, et al. Unusual Electrophoretic Pattern in a Dog Infected With Angiostrongylus vasorum. Vet Clin Pathol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40747948/

[30] Hertaeg J, Salazar U, Vom Berg J, et al. In vitro cytokine response of circulating mononuclear cells from healthy dogs to stage-specific antigens of Angiostrongylus vasorum. BMC Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41039483/

[31] Rattanapitoon NK, Charoenphon N, Arunsan P, et al. Letter to the Editor Re: Unusual Electrophoretic Pattern in a Dog Infected With Angiostrongylus vasorum. Vet Clin Pathol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41792857/

[32] Tan J, Weber S, Zuber R, et al. Endoparasites in carnivores in Swiss zoological institutions between 2009 and 2024: evaluation of risk factors and deworming strategies. Int J Parasitol Parasites Wildl. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41675580/

[33] Eisenhut B, Wittwer A, Schnyder M, et al. Host-specific vascular endothelial cell responses to Angiostrongylus vasorum: a comparative in vitro study in red foxes (Vulpes vulpes) and domestic dogs. Front Cell Infect Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40529303/

[34] Teixeira R, Flor I, Nunes T, et al. Survey of Gastrointestinal Parasites and Lungworms in Cats and Dogs from Terceira and São Miguel Islands, Azores. Pathogens. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39204248/

[35] Orioles M, Fabbri D, Miani G, et al. Double trouble: Co-infection of Angiostrongylus vasorum and Dirofilaria immitis in golden jackal (Canis aureus) in Friuli Venezia Giulia, Italy. Int J Parasitol Parasites Wildl. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39165606/